In addition, blocking CME in the refractory cell lines led to downregulate of p‐STAT3 and inhibit nuclear localization of STAT3 in vivo, combination treatment with gefitinib and a CME inhibitor resulted in tumor regression accompanying apoptosis in xenograft mouse models. The gene discussed is STAT3; the disease is neoplasm.